Metraipolis › archive › dc_9180ea5137df

Healthcare Providers' Acceptability of Cannabis And Cannabidiol to Manage Parkinson's Disease in France — Europe PMC PMID:42095066

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42095066
DOI
10.1016/j.curtheres.2026.100830
License (as archived)
solo-consultazione
Archived
2026-11-03T09:41:43.202Z
SHA-256 of the archived text
c34c05084cb7fe6d46f5c35df6e0f19e28eac41a44be8cf25c117801301b19b7
Stable URL of this page
https://metraipolis.com/documento/dc_9180ea5137df

How to cite

Healthcare Providers' Acceptability of Cannabis And Cannabidiol to Manage Parkinson's Disease in France — Europe PMC PMID:42095066 — Europe PMC (en), https://europepmc.org/article/MED/42095066 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_9180ea5137df (Metraipolis archive dc_9180ea5137df, sha256 c34c05084cb7fe6d46f5c35df6e0f19e28eac41a44be8cf25c117801301b19b7)
BibTeX
@misc{dc9180ea5137df,
  title = {Healthcare Providers' Acceptability of Cannabis And Cannabidiol to Manage Parkinson's Disease in France — Europe PMC PMID:42095066},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42095066},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_9180ea5137df; sha256 c34c05084cb7fe6d46f5c35df6e0f19e28eac41a44be8cf25c117801301b19b7},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42095066. Agents can read the archived copy with the MCP tool read_document.